The Birmingham Elderly Thyroid study. Parle J , Roberts L , Wilson S , Pattison H , Roalfe A , Haque MS , Heath C , Sheppard M , Franklyn J , Hobbs FD J Clin Endocrinol Metab. 2010 Aug;95(8):3623-32. Epub 2010 May 25. Subclinical hypothyroidism (SCH) and cognitive dysfunction are both common in the […]
Read more »Recent Posts
More on Possible Adverse Effects of Subclinical Hypothyroidism
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Rodondi N , den Elzen WP , Bauer DC , Cappola AR , Razvi S , Walsh JP , Asvold BO , Iervasi G , Imaizumi M , Collet TH , Bremner A , Maisonneuve P , Sgarbi JA , Khaw KT , Vanderpump […]
Read more »Treatment of MNG with RAI
Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. Fast S , Hegedüs L , Grupe P , Nielsen VE , Bluhme C , Bastholt L , Bonnema SJ J Clin Endocrinol Metab. 2010 Aug;95(8):3719-25. Epub 2010 Jun 2. Stimulation with recombinant human TSH (rhTSH) before […]
Read more »Radiation Exposure During Remnant Ablation
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal. Taieb D , Sebag F , Farman-Ara B , Portal T , Baumstarck-Barrau K , Fortanier C , Bourrelly M , Mancini J , De Micco C , Auquier P , Conte-Devolx B , Henry JF , Mundler […]
Read more »More Reports on Tyrosine kinase Ihibitors in Thyroid Cancer
Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. Cabanillas ME , Waguespack SG , Bronstein Y , Williams MD , Feng L , Hernandez M , Lopez A , Sherman SI , Busaidy NL J Clin Endocrinol Metab. 2010 Jun;95(6):2588-95. Epub 2010 Apr 14. Cabanillas et al […]
Read more »